The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation
Background: Many deaths from cancer are caused by metastatic burden. Prognosis and survival rates vary, but survival beyond 5 years of patients with untreated metastatic disease in the liver is rare. Treatment for liver metastases has largely been surgical resection, but this is feasible in only app...
Main Authors: | Emma Loveman, Jeremy Jones, Andrew J Clegg, Joanna Picot, Jillian L Colquitt, Diana Mendes, David J Breen, Emily Moore, Steve George, Graeme Poston, David Cunningham, Theo Ruers, John Primrose |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2014-01-01
|
Series: | Health Technology Assessment |
Subjects: | |
Online Access: | https://doi.org/10.3310/hta18070 |
Similar Items
-
Ablation therapy for patients with colorectal liver metastases with and without extrahepatic metastases: evaluation of long-term outcomes and prognostic factors
by: Jeanett Klubien, et al.
Published: (2023-07-01) -
Clinical efficacy of chemoembolization with simultaneous radiofrequency ablation for treatment of adrenal metastases from hepatocellular carcinoma
by: Hongjun Yuan, et al.
Published: (2018-07-01) -
Radiofrequency Ablation for Lung Neoplasms with Isolated Postsurgical Local
Recurrences or Metastases of Non-small Cell Lung Cancer
by: Baodong LIU, et al.
Published: (2014-06-01) -
Long-Term Survival of Two Patients with Liver Metastases from Advanced Gastric Cancer Treated with Radiofrequency Ablation and Chemotherapy
by: Sung Jin Oh
Published: (2021-02-01) -
Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma
by: Yun Xu, et al.
Published: (2017-01-01)